Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.
Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.